Plasma proteomic changes in carriers of progranulin mutations on the novel NULISA platform
Joel Simrén(University of Gothenburg), Nicholas J. Ashton(King's College London), Bingqing Zhang, Valentina Cantoni(University of Brescia), Ilenia Libri(Anna Needs Neuroblastoma Answers), Barbara Borroni(Centro San Giovanni di Dio Fatebenefratelli), Henrik Zetterberg(University of Gothenburg), Andréa L. Benedet(University of Gothenburg), Guglielmo Di Molfetta(University of Gothenburg), Kaj Blennow(Sahlgrenska University Hospital), Jasmine Rivolta(University of Brescia)
Cited by 0
Related Papers
The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease
|Alzheimer s & Dementia|2021|354
Serum neuronal exosomes predict and differentiate Parkinson’s disease from atypical parkinsonism
|Journal of Neurology Neurosurgery & Psychiatry|2020|279
Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease
|Alzheimer s & Dementia|2021|238
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy
|Neurology|2020|232
Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change
|Acta Neuropathologica|2022|229